That doesn't matter, any good scientific research needs to have a control.
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study, page-36
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.000(0.00%) |
Mkt cap ! $260.7M |
Open | High | Low | Value | Volume |
$1.56 | $1.57 | $1.53 | $56.54K | 36.79K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 779 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 5568 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 529 | 1.515 |
3 | 8895 | 1.510 |
4 | 14647 | 1.505 |
8 | 70897 | 1.500 |
1 | 647 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 5568 | 2 |
1.535 | 2334 | 2 |
1.540 | 794 | 2 |
1.545 | 1485 | 2 |
1.550 | 552 | 1 |
Last trade - 13.50pm 17/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online